Check-Cap (MBAI) Net Cash Flow Growth (1y) (2015 - 2024)
Check-Cap (MBAI) Net Cash Flow Growth (1y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -260.86% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 73.93% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 722.22% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -115.29% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -58.16% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 73.12% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -441.96% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 84.25% |
| 10 | Check-Cap | 8.04 Mn | 6.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 99.58% |
| Dec 31, 2023 | -308.73% |
| Sep 30, 2023 | 4,403.72% |
| Jun 30, 2023 | 120.05% |
| Mar 31, 2023 | -62.48% |
| Dec 31, 2022 | -141.27% |
| Sep 30, 2022 | -100.28% |
| Jun 30, 2022 | -131.05% |
| Mar 31, 2022 | 133.60% |
| Dec 31, 2021 | 844.70% |
| Sep 30, 2021 | 3,447.94% |
| Jun 30, 2021 | -781.36% |
| Mar 31, 2021 | 1,488.30% |
| Dec 31, 2020 | 135.84% |
| Sep 30, 2020 | -69.38% |
| Jun 30, 2020 | 404.99% |
| Mar 31, 2020 | -70.07% |
| Dec 31, 2019 | 19.42% |
| Sep 30, 2019 | 18.34% |
| Jun 30, 2019 | 102.71% |